A novel Gorilla-derived oncolytic Adenovirus with natural selective replication in cancer cells
Romina Scala, Ilaria Cela, Emily Capone, Valentina Proganò, Angiolo Pierantoni, Stefano Colloca, Gianluca Sala, Angelo Raggioli
This paper develops a novel gorilla-derived oncolytic adenovirus, GRAd32Fk25, which selectively replicates in tumor cells and expresses a therapeutic antibody, showing potential as an improved virotherapy compared to HAd5.
bioRxiv · Mar 1, 2026 · PreprintCancer Biology